[Bacteriological results of the 6 months' continuous treatment of pulmonary tuberculosis with the triple antibacterial combination: streptomycin, isoniazid and para-amino-salicylic acid; comparison with univalent or bivalent antibacterial therapy].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents; D007538:Isoniazid; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D020156:Salicylic Acid; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D000900:Anti-Bacterial Agents; D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D020156:Salicylic Acid; D007538:Isoniazid; D013307:Streptomycin
NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy
Résultat bactériologique du traitement continu, pendant six mois, de la tuberculose pulmonaire par l'association antibacillaire triple: streptomycine, isoniazide, acide para-amino-salicylique; comparaison avec les traitements antibacillaires monovalents ou bivalents.